Alnylam Pharmaceuticals Inc. (ALNY) fell -6.6% or -6.43 to $90.95. It is around 3.91 million shares traded, which is 532.12% compare to the average total volume 735439. The market cap of ALNY is $9.16 billion. The year to date change is -32.75%. The 52 week price range is from $70.76 to $153.99. Price of ALNY have changed 4.63% during last week. It have changed -9.88% over last month, -5.58% over last 3 months, -16.98% over last 6 months and 22.28% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ALNY is 101.19. It is 11.26% above current price. The 200-day Moving Averages for ALNY is 115.02. It is 26.47% above current price. The 52-week High is 153.99. It is 69.31% from the current price. The 52-week Low is 70.76. It is -22.20% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ALNY is 7.96 on 2018-07-31. Short % to float is 5.00%. There are some statistics of ALNY. It is has market cap $9.16 billion. The share outstanding is 100.67 million. The average volume is 735439. The revenue is 55.02M. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ALNY is -41.54%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ALNY is -35.36%.